Clinical and pharmacological group: & nbsp

NSAIDs - Propionic acid derivatives

Correctors of bone and cartilage tissue metabolism

Included in the formulation
  • Teraflex® Advance
    capsules inwards 
    BAYER, AO     Russia
  • АТХ:

    M.01.A.E.51   Ibuprofen in combination with other drugs

    Pharmacodynamics:

    Combined drug.

    Glucosamine

    Stimulates the development of matrix cartilage tissue, promotes regeneration processes, has a moderate anti-inflammatory effect.

    Ibuprofen

    Non-selective reversible cyclooxygenase inhibitor, an enzyme that catalyzes the reaction of the conversion of arachidonic acid to prostaglandin H2, which is the precursor of the remaining prostaglandins, thromboxane A2 and prostacyclin. Has anti-inflammatory and analgesic, as well as antipyretic effect. It inhibits the aggregation of platelets.

    Ibuprofen also inhibits the synthesis of leukotrienes, reduces bradykinin activity, stabilizes lysosomal membranes. With articular syndrome reduces the severity of arthralgia (at rest and during movement), morning stiffness and swelling of the joints, helps reduce the degree of their functional insufficiency.

    Chondroitin sulfate

    It is the main component of proteoglycans, which together with collagen fibers constitute the matrix of cartilage. It acts as a chondroprotector, suppresses the activity of enzymes that promote degradation of the cartilaginous surface of the joint, activates metabolism in the subchondral bone, stimulates the production of proteoglycans by chondrocytes, and regenerates cartilage tissue. Has analgesic and anti-inflammatory effect, inhibits the secretion of prostaglandin E2 and leukotriene B4, reduces the excretion of inflammatory mediators in the synovial fluid.

    Prevents the collapse of connective tissue, promotes the restoration of articular surfaces, improves the production of intraarticular fluid, which improves mobility in the joint and reduces the intensity of pain.

    Pharmacokinetics:

    Glucosamine

    After oral administration, it is absorbed in the gastrointestinal tract. It is subjected to primary metabolism in the liver. Bioavailability is 25%. Up to 30% of the amount of the drug taken is accumulated in bone and muscle tissue.

    The half-life is 68 hours. Elimination with feces.

    Ibuprofen

    After oral administration, up to 80% is absorbed in the gastrointestinal tract.The maximum concentration in the blood plasma is achieved in 1-2 hours.

    After absorption, about 60% of the pharmacologically inactive R-form is slowly transformed into an active S-form. The connection with plasma proteins is 99%. The therapeutic concentration persists longer in the synovial fluid than in the blood plasma. The onset of action of the drug with pain syndrome occurs after 0.5 hours and reaches a maximum after 2-4 hours, lasts for 4-6 hours.

    Metabolism in the liver.

    The half-life is 6-7 days. Elimination by the kidneys.

    Chondroitin sulfate

    After oral administration, up to 13% is absorbed in the gastrointestinal tract. The maximum concentration in the blood plasma is achieved in 3-4 hours. After 4-5 hours, it accumulates in the synovial fluid.

    The half-life is 68 hours. Elimination with feces.

    Indications:

    It is used for the treatment of arthrosis, osteochondrosis, arthralgia, accompanied by a moderate pain syndrome.

    XIII.M15-M19.M15   Polyarthrosis

    XIII.M15-M19.M16   Coxarthrosis [arthrosis of the hip joint]

    XIII.M15-M19.M17   Gonarthrosis [knee arthrosis]

    XIII.M20-M25.M25.5   Pain in the joint

    XIII.M40-M43.M42   Osteocondritis of the spine

    XIII.M50-M54.M54   Dorsalgia

    XIII.M50-M54.M54.5   Lower back pain

    Contraindications:

    The risk of angioedema, bronchospastic syndrome, gastric and duodenal ulcer, ulcerative colitis, gastritis, individual intolerance, bleeding in the gastrointestinal tract, phenylketonuria, glucose-6-phosphate dehydrogenase deficiency, portal hypertension, anemia, leukopenia, pregnancy and lactation, age to 18 years, individual intolerance.

    Carefully:

    Severe renal and hepatic insufficiency, hypersensitivity.

    Pregnancy and lactation:

    Recommendations for FDA - Category C. Contraindicated in pregnancy and lactation.

    Dosing and Administration:

    Inside, after eating, 2 capsules 3 times a day for 3 weeks.

    The highest daily dose: 6 capsules.

    The highest single dose: 2 capsules.

    Side effects:

    Central and peripheral nervous system: dizziness, drowsiness, confusion, hallucinations.

    Respiratory system: shortness of breath, bronchospasm.

    Hemopoietic system: eosinophilia, rarely - thrombocytopenia.

    The cardiovascular system: tachycardia, arterial hypertension.

    Digestive system: aphthous stomatitis, nausea, heartburn, diarrhea, hepatitis, pancreatitis.

    Dermatological reactions: Hyperhidrosis.

    Sense organs: amblyopia, tinnitus, reduced hearing acuity.

    urinary system: nephrotic syndrome, cystitis, polyuria, rarely oliguria.

    Allergic reactions.

    Overdose:

    Pain in epigastrium, nausea, vomiting, drowsiness. Rarely - gastrointestinal bleeding, muscle twitching, respiratory depression, coma.

    Symptomatic therapy.

    Interaction:

    Increases the effectiveness of oral hemocoagulants.

    With simultaneous use with barbiturates, narcotic analgesics, caffeine, phenothiazine derivatives, diphenhydramine, phenacetin, analgesic effects are enhanced.

    Anti-inflammatory effect increases salicylates and metamizol sodium.

    Increases the absorption of tetracyclines.

    Reduces the effects of semisynthetic penicillins.

    Chondroitin sulfate enhances the effect of anticoagulants.

    Special instructions:

    When taking the drug is not recommended driving and working with moving machinery.

    Instructions
    Up